PEPTIDE
DUE DILIGENCE

Research library

Build a better documentation instinct.

Evidence-focused guides to analytical methods, quality attributes, regulatory status, and supplier documentation.

Educational collection

Start with the fundamentals.

Every guide names its scope, limitations, updated date, and primary sources.

COA literacy

How to Read a Peptide Certificate of Analysis

A field guide to identity, purity, lot matching, dates, methods, and the limits of the document in front of you.

7 min readRead guide

Data literacy

What “99% Purity” Actually Tells You

Why a headline percentage is meaningful only when you know the method, calculation, sample, and missing measurements.

6 min readRead guide

Laboratory standards

How to Evaluate Third-Party Laboratory Testing

A practical way to assess laboratory identity, independence, accreditation scope, and report traceability.

7 min readRead guide

Supplier standards

Research Peptide Vendor Red Flags

Documentation and business-practice signals that should trigger more questions before laboratory procurement.

8 min readRead guide

Analytical methods

HPLC vs. Mass Spectrometry: What Each Test Shows

Two complementary techniques, two different questions, and why a complete report often needs both.

7 min readRead guide

Peptide fundamentals

What Are Peptides? A Research-Focused Introduction

A plain-language introduction to amino-acid chains, sequence, structure, function, and why the word peptide describes a broad class—not a single effect.

9 min readRead guide

Label literacy

What Does “Research Grade” Mean?

Why research grade is not a universal regulatory quality standard—and which specifications and records matter more than the label.

8 min readRead guide

Regulatory literacy

FDA-Approved vs. Experimental Peptides

How to distinguish an approved drug product, an investigational drug, a compounded preparation, and a material sold for laboratory research.

10 min readRead guide

Quality fundamentals

Identity, Purity, Quantity, Sterility, and Endotoxin Explained

Five separate quality questions, the evidence used to address them, and why no single headline result can answer all five.

11 min readRead guide

Peptide evidence

BPC-157 Research: What the Evidence Actually Shows

A plain-language evidence map separating laboratory findings, animal studies, limited human data, and the questions that remain unanswered.

10 min readRead guide

Naming clarity

TB-500 vs. Thymosin Beta-4: Are They the Same Compound?

Why the names are often used interchangeably online, what the scientific literature actually studies, and what researchers should verify.

9 min readRead guide

Naming clarity

CJC-1295 With DAC vs. Without DAC: Why the Name Matters

A careful guide to CJC-1295 terminology, albumin binding, Mod GRF 1-29, and the labeling details researchers should confirm.

9 min readRead guide

Peptide evidence

GHK-Cu Research: Evidence, Mechanisms, and Open Questions

A grounded review of copper-binding GHK research across cell models, tissue-repair experiments, skin studies, and unresolved questions.

10 min readRead guide

Peptide evidence

MOTS-c Research: What the Evidence Actually Shows

A research-use overview of MOTS-c evidence across cell models, animal metabolic studies, human biomarker research, clinical-trial status, and supplier documentation limits.

11 min readRead guide

Peptide evidence

Ipamorelin Research: What Human and Preclinical Studies Show

A clear evidence map for ipamorelin, separating receptor and animal findings, early human pharmacology, a phase 2 trial, and unanswered questions.

10 min readRead guide

Naming clarity

Kisspeptin-10 vs. Kisspeptin-54: Why Fragment Length Matters

A research-focused comparison of KP-10 and KP-54, including shared receptor biology, different in-vivo behavior, human evidence, and identity checks.

10 min readRead guide

Peptide evidence

Retatrutide Research: Clinical Evidence vs. Online Product Claims

A stage-by-stage review of retatrutide receptor, animal, and human evidence—and why clinical-trial material is not equivalent to online research products.

12 min readRead guide

Peptide evidence

Tesamorelin Research: FDA-Approved Product vs. Broader Peptide Claims

A clear evidence map for tesamorelin, separating receptor and animal findings, the approved HIV-lipodystrophy evidence, broader human studies, and online product claims.

12 min readRead guide

Research procurement

KPV Research Supplier Checklist: Identity, Testing, and Evidence Limits

A research-use checklist for evaluating KPV listings, separating cell and animal findings from human evidence gaps and translating the chemistry into useful COA questions.

12 min readRead guide

Peptide evidence

AOD-9604 Research: Preclinical Signals, Human Trial Results, and Evidence Limits

A stage-by-stage review of AOD-9604, separating cell and animal findings from the human obesity program, FDA's compounding review, and supplier-documentation questions.

13 min readRead guide

Peptide evidence

Thymosin Alpha-1 Research: Immune Signaling, Human Trials, and Evidence Limits

A stage-by-stage review of thymosin alpha-1 (thymalfasin), separating cell and animal immune research, mixed human trial evidence, U.S. regulatory status, and supplier documentation.

13 min readRead guide

Peptide evidence

LL-37 Research: Host-Defense Biology, Human Trials, and Evidence Limits

A stage-by-stage review of LL-37 research, separating cell and animal findings, human wound trials, inflammatory signals, and supplier documentation.

14 min readRead guide

Peptide evidence

Bremelanotide (PT-141) Research: What FDA Approval Does—and Does Not—Mean

A stage-by-stage review of bremelanotide and PT-141 receptor studies, animal models, phase 3 trials, FDA labeling, and research-vial documentation.

14 min readRead guide

Peptide evidence

Semaglutide Research: From GLP-1 Analogue Design to Major Human Trials

A stage-by-stage review of semaglutide design, receptor and animal studies, major human trials, FDA-approved products, and research-vial identity limits.

15 min readRead guide

Peptide evidence

Hexarelin Research: Receptor Biology, Animal Studies, and Human Evidence

A stage-by-stage review of hexarelin, separating receptor and cell findings, animal cardiovascular models, small human studies, and research-material documentation.

13 min readRead guide

Peptide evidence

Sermorelin Research: GHRH Biology, Human Studies, and FDA History

A stage-by-stage review of sermorelin, separating receptor and animal findings, older human studies, historical FDA product status, and research-material documentation.

14 min readRead guide

Peptide evidence

Gonadorelin Research: GnRH Signaling, Pulse Biology, and FDA History

A stage-by-stage review of gonadorelin, separating receptor and cell findings, animal pulse-pattern research, human endocrine studies, FDA history, and research-material documentation.

14 min readRead guide

Peptide evidence

Semax Research: ACTH-Fragment Biology, Animal Studies, and Human Evidence

A stage-by-stage review of Semax research, separating cell and animal findings, small human studies, regulatory status, and supplier-documentation limits.

14 min readRead guide

COA literacy

How to Check Whether a Peptide COA Is Authentic

A practical verification workflow for report numbers, laboratories, lot matching, document integrity, and unresolved evidence.

9 min readRead guide

Analytical methods

How to Read an HPLC Chromatogram

A beginner-friendly guide to axes, peaks, retention time, integration, area percentage, resolution, and common interpretation limits.

10 min readRead guide

Analytical methods

How to Read a Peptide Mass-Spectrometry Report

How expected mass, observed ions, charge states, adducts, resolution, and sample traceability contribute to identity evidence.

10 min readRead guide

Material composition

Peptide Counterions and Salt Forms Explained

Why acetate, trifluoroacetate, chloride, and other counterions affect composition, reporting, and cross-supplier comparisons.

8 min readRead guide

Manufacturing literacy

What Is Lyophilization?

How freeze-drying works, what a lyophilized cake can reveal, and why appearance does not establish content or stability.

9 min readRead guide

Impurity testing

Residual Solvents in Peptide Testing

What residual solvents are, why peptide purity does not measure them, and how specifications and method-specific results should be reviewed.

9 min readRead guide

Quantitative analysis

Water Content vs. Net Peptide Content

Why vial mass, residual moisture, counterions, purity, and quantitative peptide content are separate numbers.

9 min readRead guide

Stability evidence

How to Evaluate Peptide Stability and Expiration Claims

A framework for reviewing storage conditions, time points, stability-indicating methods, container systems, and extrapolated shelf-life claims.

10 min readRead guide

Laboratory standards

How to Verify an ISO/IEC 17025 Accreditation Scope

How to check the accreditation body, certificate status, laboratory location, scope document, methods, and exclusions behind an ISO 17025 claim.

9 min readRead guide

Sampling evidence

Seller-Submitted vs. Independently Purchased Testing

Why laboratory independence and sample independence are different—and how procurement, custody, and selection affect the strength of evidence.

9 min readRead guide

Traceability

What Does Batch-Specific Testing Mean?

How lot definitions, sample identifiers, manufacturing records, and public COAs connect a test result to inventory.

8 min readRead guide

Pricing literacy

How to Compare Peptide Prices Accurately

A transparent comparison method for nominal quantity, verified content, testing, shipping, discounts, and documentation quality.

9 min readRead guide

Stability analysis

Peptide Degradation Products: Oxidation, Deamidation, and Truncation

How oxidation, deamidation, hydrolysis, and truncation change peptide materials—and what HPLC, LC-MS, stress studies, and supplier documents can actually establish.

13 min readRead guide